BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35857132)

  • 41. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
    Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study.
    Mehrabani HH; Salehpour S; Amiri Z; Farahani SJ; Meyer BJ; Tahbaz F
    J Am Coll Nutr; 2012 Apr; 31(2):117-25. PubMed ID: 22855917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metformin therapy in women with polycystic ovary syndrome.
    Aruna J; Mittal S; Kumar S; Misra R; Dadhwal V; Vimala N
    Int J Gynaecol Obstet; 2004 Dec; 87(3):237-41. PubMed ID: 15548396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Ahmadi S; Jamilian M; Karamali M; Tajabadi-Ebrahimi M; Jafari P; Taghizadeh M; Memarzadeh MR; Asemi Z
    Hum Fertil (Camb); 2017 Dec; 20(4):254-261. PubMed ID: 28142296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
    Deswal R; Nanda S; Dang AS
    Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome.
    Ciccone MM; Favale S; Bhuva A; Scicchitano P; Caragnano V; Lavopa C; De Pergola G; Loverro G
    Vasc Health Risk Manag; 2009; 5(3):561-6. PubMed ID: 19590590
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment with combined resveratrol and myoinositol ameliorates endocrine, metabolic alterations and perceived stress response in women with PCOS: a double-blind randomized clinical trial.
    Hassan S; Shah M; Malik MO; Ehtesham E; Habib SH; Rauf B
    Endocrine; 2023 Jan; 79(1):208-220. PubMed ID: 36169918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin-like factor 3 -- a new hormone related to polycystic ovary syndrome?
    Szydlarska D; Grzesiuk W; Trybuch A; Kondracka A; Kowalik I; Bar-Andziak E
    Endokrynol Pol; 2012; 63(5):356-61. PubMed ID: 23115068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial.
    Zhang J; Xing C; Cheng X; He B
    Front Endocrinol (Lausanne); 2022; 13():1003238. PubMed ID: 36147577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Associations between adipocyte fatty acid-binding protein and clinical parameters in polycystic ovary syndrome.
    Doğanay M; Ozyer SS; Var T; Tonguc E; Gun Eryilmaz O; Ozer I; Guzel AI
    Arch Gynecol Obstet; 2015 Feb; 291(2):447-50. PubMed ID: 25138125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of abdominal acupuncture therapy on the endocrine and metabolism in obesity-type polycystic ovarian syndrome patients].
    Lai MH; Ma HX; Yao H; Liu H; Song XH; Huang WY; Wu XK
    Zhen Ci Yan Jiu; 2010 Aug; 35(4):298-302. PubMed ID: 21090334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomised controlled trial to study the efficacy of exercise with and without metformin on women with polycystic ovary syndrome.
    Tiwari N; Pasrija S; Jain S
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():149-154. PubMed ID: 30690191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Effects of Synbiotic Supplementation on Metabolic Status in Women With Polycystic Ovary Syndrome: a Randomized Double-Blind Clinical Trial.
    Samimi M; Dadkhah A; Haddad Kashani H; Tajabadi-Ebrahimi M; Seyed Hosseini E; Asemi Z
    Probiotics Antimicrob Proteins; 2019 Dec; 11(4):1355-1361. PubMed ID: 29532416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mediterranean Diet Combined With a Low-Carbohydrate Dietary Pattern in the Treatment of Overweight Polycystic Ovary Syndrome Patients.
    Mei S; Ding J; Wang K; Ni Z; Yu J
    Front Nutr; 2022; 9():876620. PubMed ID: 35445067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Predictive Role of Serum Cystatin C Levels in Polycystic Ovary Syndrome in Adolescents.
    Çınar M; Aksoy RT; Güzel Aİ; Tokmak A; Çandar T; Taşçı Y
    J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):353-6. PubMed ID: 26740281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sleep Duration, Exercise, Shift Work and Polycystic Ovarian Syndrome-Related Outcomes in a Healthy Population: A Cross-Sectional Study.
    Lim AJ; Huang Z; Chua SE; Kramer MS; Yong EL
    PLoS One; 2016; 11(11):e0167048. PubMed ID: 27870902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.
    Huber-Buchholz MM; Carey DG; Norman RJ
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1470-4. PubMed ID: 10199797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome.
    Yin D; Ruan X; Tian X; Du J; Zhao Y; Cui Y; Li Y; Mueck AO
    Gynecol Endocrinol; 2017 Apr; 33(4):332-335. PubMed ID: 28051891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.